Su1006 Risk of Relapse After Azathioprine (AZA) Discontinuation in Inflammatory Bowel Disease (IBD) Patients in Maintained Remission
暂无分享，去创建一个
M. Iborra | P. Nos | B. Beltrán | X. Cortés | M. Boscá-Watts | J. Herreras | B. Navarro | Mariana Martinez | G. Trejo